NCT04748458

Brief Summary

A retrospective consecutive population of patients treated with conical tapered stems in cementless total hip arthroplasty for osteoarthritis due to congenital hip pathologies will be selected. The aim of this retrospective study is to evaluate the long-term clinical and radiographic results of this implant and the survival rates in such a specific cohort.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 17, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 27, 2020

Completed
4 months until next milestone

First Posted

Study publicly available on registry

February 10, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 2, 2021

Completed
6 months until next milestone

Results Posted

Study results publicly available

March 22, 2022

Completed
Last Updated

March 22, 2022

Status Verified

October 1, 2020

Enrollment Period

1.2 years

First QC Date

October 27, 2020

Results QC Date

October 5, 2021

Last Update Submit

March 21, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Harris Hip Score

    Mean clinical results at last follow-up evaluated using the Harris hip score. Minimum-maximum values: 0-100. Best result: 100.

    15 months

  • Survival Rate

    Percentage of survived implants (no component exchange or removed) described using Kaplan-Meier curve with 95% confidence interval. Minimum-maximum values: 0-100. Best result: 100.

    15 months

  • Radiographic Cup Osseointegration

    Osseointegrated cups described using the Moore's criteria: the cup is osseointegrated when at least 3 criteria are present (radial trabeculae, superolateral buttress, inferolateral buttress, medial stress shielding, absence of radiolucent lines).

    15 months

  • Radiographic Stem Osseointegration

    Osseointegrated stems described according to Engh's criteria

    15 months

Study Arms (1)

Congenital hip pathologies

Conical tapered stem for osteoarthritis due to congenital hip pathologies

Device: Conical tapered stem

Interventions

Implantation of conical tapered stem

Congenital hip pathologies

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

retrospective, consecutive adult population treated with conical tapered stems in cementless total hip arthroplasty for osteoarthritis due to congenital hip pathologies.

You may qualify if:

  • Symptomatic hip osteoarthritis due to congenital hip pathologies
  • Consecutive population with a minimum follow-up of 2 years
  • Cementless total hip arthroplasty with conical tapered stem
  • Pre-operative planning using CT
  • Complete clinical and radiographic assessment

You may not qualify if:

  • Other type of hip osteoarthritis
  • Other type of implants
  • Inadequate pre-operative planning (eg: no CT)
  • Incomplete clinical and radiographic assessment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chirurgia Protesica e dei Reimpianti di Anca e Ginocchio, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy

Bologna, 40136, Italy

Location

Related Publications (5)

  • Greber EM, Pelt CE, Gililland JM, Anderson MB, Erickson JA, Peters CL. Challenges in Total Hip Arthroplasty in the Setting of Developmental Dysplasia of the Hip. J Arthroplasty. 2017 Sep;32(9S):S38-S44. doi: 10.1016/j.arth.2017.02.024. Epub 2017 Feb 22.

  • Perry KI, Berry DJ. Femoral considerations for total hip replacement in hip dysplasia. Orthop Clin North Am. 2012 Jul;43(3):377-86. doi: 10.1016/j.ocl.2012.05.010.

  • Argenson JN, Flecher X, Parratte S, Aubaniac JM. Anatomy of the dysplastic hip and consequences for total hip arthroplasty. Clin Orthop Relat Res. 2007 Dec;465:40-5. doi: 10.1097/BLO.0b013e3181576052.

  • Pak P, de Steiger R. Cone femoral prosthesis for osteoarthritis of the hip with femoral dysplasia. J Orthop Surg (Hong Kong). 2008 Aug;16(2):206-10. doi: 10.1177/230949900801600216.

  • Taniguchi N, Jinno T, Koga D, Hagino T, Okawa A, Haro H. Cementless Hip Stem Anteversion in the Dysplastic Hip: A Comparison of Tapered Wedge vs Metaphyseal Filling. J Arthroplasty. 2017 May;32(5):1547-1552. doi: 10.1016/j.arth.2016.12.020. Epub 2016 Dec 22.

MeSH Terms

Conditions

Hip DislocationProsthesis Failure

Condition Hierarchy (Ancestors)

Joint DislocationsJoint DiseasesMusculoskeletal DiseasesWounds and InjuriesHip InjuriesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr Francesco Castagnini
Organization
IRCCS Istituto Ortopedico Rizzoli

Study Officials

  • Francesco Traina, Prof

    IRCCS Istituto Ortopedico Rizzoli, Bologna, ITaly

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 27, 2020

First Posted

February 10, 2021

Study Start

July 17, 2020

Primary Completion

October 1, 2021

Study Completion

October 2, 2021

Last Updated

March 22, 2022

Results First Posted

March 22, 2022

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations